Arbutus Biopharma Stock Price (NASDAQ:ABUS)

Add to My Stocks
$3.75 $0.05 (1.35%) ABUS stock closing price Jul 26, 2017 (Closing)
Prev Close* : $3.70
Market Cap:
Day Low: $3.65
52 Week Low: $2.35
Open: $3.7
Volume: 116594
Day High: $3.75
52 Week High: $4.49

Latest Stock Market News

Latest Articles

Arbutus Biopharma News - From Partners

Arbutus Announces ARB-1467 Data Presentation at EASL   by Globe Newswire on Apr 22, 2017

ABUS Stockcharts

View ABUS PE ratio, PS ratio stocks charts and compare with peers.
ABUS Chart
Note: Compare Arbutus Biopharma stock price history with the index and industry peers.

Arbutus Biopharma Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Arbutus Biopharma Financial Ratios

Receivables Turnover
Debt to Equity

ABUS Industry Peers

Company Price Change (%)
Kindred Biosciences (KIN)7.60.15 (1.94%)
Kamada (KMDA)5.150.25 (4.63%)
Alnylam Pharma (ALNY)81.570.56 (0.69%)
Dicerna Pharma (DRNA)3.980.33 (7.66%)
Arrowhead Pharma (ARWR)1.880.28 (17.5%)
Marina Biotech (MRNA)0.340.01 (2.86%)
Benitec Biopharma (BNTC)2.340.03 (1.27%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
EXACT Sciences (EXAS)39.652.32 (6.21%)
Dynavax Technologies (DVAX)10.40.5 (5.05%)
MannKind (MNKD)1.320.06 (4.76%)
BioDelivery Sciences (BDSI)3.50.15 (4.48%)
Biogen Inc (BIIB)295.6112.65 (4.47%)
Paratek Pharma (PRTK)21.450.85 (4.13%)
Vital Therapies (VTL)2.750.1 (3.77%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jul 27, 2017
CompanyPriceChange (%)
Integra LifeSciences (IART)49.745.88 (10.57%)
Idera Pharma (IDRA)1.940.12 (5.83%)
Kamada (KMDA)5.150.25 (4.63%)
Peregrine Pharma (PPHM)4.30.2 (4.44%)
Fate Therapeutics (FATE)2.830.11 (3.74%)
Compugen (CGEN)3.90.15 (3.7%)
Trevena (TRVN)2.720.1 (3.55%)
Top losers from Medical-Biomed-Genetics industry
* As of Jul 27, 2017

Arbutus Biopharma Corp Stock News - Partner Headlines

Arbutus Biopharma Financial Statements

income statement20162015201420132012
Net Sales Or Revenues1.49M24.87M14.95M15.46M14.1M
Net Income-384.16M-61.12M-38.83M-14.06M29.79M
Total Operating Expense493.11M127.18M47.91M27.6M27.02M
view Arbutus Biopharma Corp income statement
balance sheet20162015201420132012
Total Assets275.91M712.29M118.17M71.71M52.32M
Total Liabilities72.91M164.61M30.14M12.52M11.61M
Shareholders Equity203M547.67M88.03M59.19M40.71M
view Arbutus Biopharma Corp balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-0.46M-14.63M16.51M2.29M-2.43M
Net Cash From (Used By) Operating Activities-57.88M-54.78M-12.42M-6.73M33.11M
Increase (Decrease) In Prop Plant And Equipment-3.97M-2.28M-0.97M-0.72M-0.01M
view Arbutus Biopharma Corp cashflow statement

Arbutus Biopharma Stock Message Board

An investor needs to spend 3.75 to buy ABUS stock, as the closing Arbutus Biopharma stock price is 3.75. Looking at Arbutus Biopharma market capitalization, which currently stands at 203.59M, we can say that ABUS stock is a Micro cap stock. Arbutus Biopharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

Demand for a stock decides its stock market price. For example, if more investors want to buy ABUS stock than sell it, then Arbutus Biopharma stock price goes up. Conversely, if more investors wanted to sell ABUS stock than buy it, there would be greater supply than demand, and the stock price would fall. 116594 ABUS shares were traded yesterday, and Arbutus Biopharma stock chart shows that the ABUS stock quote hit a day high of 3.75 and day low of 3.65. A dividend is a cash payment from a company's earnings and is distributed among shareholders. Arbutus Biopharma does not pay dividends. Arbutus Biopharma stock price history, gives the entire historical data for ABUS stock.